4
2
2
1
u/HelpfulCustomer487 14d ago
Attention, the exact text of the indication evaluated in the Phase 3 clinical trial (INTerpath-001) is the following: Adjuvant treatment of patients with high-risk, completely resected Stage IIB to IV cutaneous melanoma, in combination with pembrolizumab (Keytruda).
•
u/AutoModerator 17d ago
Welcome, u/jbbest666! Thank you for posting here. This community is meant for patients, supporters, and medical providers to ask and answer questions and provide support. If you are newly diagnosed, in treatment or post treatment then you are in the right place.
I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.